Researchers investigated whether ABBV-599 could increase the treatment response for patients with RA compared with JAK inhibitor or BTK inhibitor alone.
Researchers investigated the risk for infection between leflunomide vs TNFi and tacrolimus vs TFNi among patients with rheumatoid arthritis treated with concomitant methotrexate.
Researchers assessed the effect of clinical characteristics and treatment options on the prognosis of patients with rheumatoid arthritis-associated interstitial lung disease.
Researchers compared physician- and patient-reported measures of tofacitinib therapy to determine the impact of long-term treatment among patients with rheumatoid arthritis.
Researchers investigated treatment responses to sequential lines of biologic or targeted synthetic DMARD therapy in patients with RA to determine if they experienced benefits from a trial-and-error approach to treatment.
Researchers assessed the risks for short-, intermediate-, and long-term acute coronary syndrome among patients with rheumatoid arthritis initiating treatment with biologic disease-modifying antirheumatic drugs.